These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 26308488

  • 21. Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
    Padhy M, Kaushik S, Girish MP, Mohapatra S, Shah S, Koner BC.
    Clin Chim Acta; 2014 Aug 05; 435():48-52. PubMed ID: 24804935
    [Abstract] [Full Text] [Related]

  • 22. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention.
    Ohno Y, Maekawa Y, Miyata H, Inoue S, Ishikawa S, Sueyoshi K, Noma S, Kawamura A, Kohsaka S, Fukuda K.
    J Am Coll Cardiol; 2013 Oct 01; 62(14):1260-1266. PubMed ID: 23770181
    [Abstract] [Full Text] [Related]

  • 23. Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.
    Hafiz AM, Jan MF, Mori N, Shaikh F, Wallach J, Bajwa T, Allaqaband S.
    Catheter Cardiovasc Interv; 2012 May 01; 79(6):929-37. PubMed ID: 21542114
    [Abstract] [Full Text] [Related]

  • 24. Asymmetric dimethylarginine predicts the risk of contrast-induced acute kidney injury in patients undergoing cardiac catheterization.
    Lu TM, Hsu CP, Chang CF, Lin CC, Lee TS, Lin SJ, Chan WL.
    Atherosclerosis; 2016 Nov 01; 254():161-166. PubMed ID: 27744140
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy and Safety of Coronary Sinus Aspiration During Coronary Angiography to Attenuate the Risk of Contrast-Induced Acute Kidney Injury in Predisposed Patients.
    Diab OA, Helmy M, Gomaa Y, El-Shalakany R.
    Circ Cardiovasc Interv; 2017 Jan 01; 10(1):e004348. PubMed ID: 28049622
    [Abstract] [Full Text] [Related]

  • 28. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A, Leoncini M, Maioli M, Tropeano F, Di Vincenzo E, Villani S, Bellandi F.
    JACC Cardiovasc Interv; 2014 Dec 01; 7(12):1421-9. PubMed ID: 25523533
    [Abstract] [Full Text] [Related]

  • 29. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography.
    Morabito S, Pistolesi V, Benedetti G, Di Roma A, Colantonio R, Mancone M, Sardella G, Cibelli L, Ambrosino M, Polistena F, Pierucci A.
    J Nephrol; 2012 Dec 01; 25(6):1098-107. PubMed ID: 22383347
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
    Bei WJ, Duan CY, Chen JY, Wang K, Liu YH, Liu Y, Tan N.
    J Cardiovasc Pharmacol Ther; 2016 Jan 01; 21(1):53-63. PubMed ID: 26112028
    [Abstract] [Full Text] [Related]

  • 32. Elevated serum fibrinogen levels and risk of contrast-induced acute kidney injury in patients undergoing a percutaneous coronary intervention for the treatment of acute coronary syndrome.
    Celik IE, Kurtul A, Duran M, Yarlioglues M, Elcik D, Kilic A, Koseoglu C, Oksuz F, Murat SN.
    Coron Artery Dis; 2016 Jan 01; 27(1):13-8. PubMed ID: 26267748
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M, Cengiz H, Hoeltgen R, Wieczorek M, Boedeker RH, Scheibelhut C, Boening A.
    J Invasive Cardiol; 2013 Jun 01; 25(6):276-83. PubMed ID: 23735352
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L, Falsini G, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C.
    J Cardiovasc Med (Hagerstown); 2010 Mar 01; 11(3):199-206. PubMed ID: 19829124
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Use of Both Serum Cystatin C and Creatinine as Diagnostic Criteria for Contrast-Induced Acute Kidney Injury and Its Clinical Implications.
    Zhang WF, Zhang T, Ding D, Sun SQ, Wang XL, Chu SC, Shen LH, He B.
    J Am Heart Assoc; 2017 Jan 13; 6(1):. PubMed ID: 28087509
    [Abstract] [Full Text] [Related]

  • 40. Renal function-adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary intervention.
    Andò G, de Gregorio C, Morabito G, Trio O, Saporito F, Oreto G.
    Circ Cardiovasc Interv; 2014 Aug 13; 7(4):465-72. PubMed ID: 25027519
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.